Literature DB >> 10440894

Ciliary neurotrophic factor induces expression of the IGF type I receptor and FGF receptor 1 mRNAs in adult rat brain oligodendrocytes.

F Jiang1, S W Levison, T L Wood.   

Abstract

Ciliary neurotrophic factor (CNTF) is produced and released in response to injury in the central nervous system (CNS). While CNTF initially was characterized as a trophic factor for neurons, more recent evidence supports roles for this factor in survival, proliferation, and maturation of oligodendrocyte lineage cells. Evidence is emerging to support the hypothesis that CNTF's actions may include enhancing other growth and trophic factors. Here we tested the hypothesis that CNTF can induce expression of receptors on oligodendrocytes for factors that are known to promote their generation, maturation, and survival. Specifically, we used an in vivo paradigm to test whether CNTF, when injected stereotactically into forebrain white matter of adult rats, could induce mRNA expression for the insulin-like growth factor (IGF) type I receptor (IGF-IR), fibroblast growth factor (FGF) receptor (FGFR)-1, FGFR3, and platelet-derived growth factor (PDGF) receptor-alpha (PDGFRalpha). We determined that CNTF injection increased expression of IGF-IR and FGFR1 mRNAs in adult white matter to 200-250% of control levels. Cellular analysis indicated that these receptor mRNAs were induced in interfascicular oligodendrocytes. In contrast, CNTF had no effect on levels of FGFR3 and PDGFRalpha mRNAs. These results suggest that CNTF enhances the sensitivity of oligodendrocytes to other mitogens and trophic factors via induction of their receptors. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440894

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

Review 1.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 2.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

Review 3.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 4.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

5.  Neuronal activity and axonal sprouting differentially regulate CNTF and CNTF receptor complex in the rat supraoptic nucleus.

Authors:  Jason M Askvig; Laura J Leiphon; John A Watt
Journal:  Exp Neurol       Date:  2011-10-19       Impact factor: 5.330

6.  CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors.

Authors:  Phillip J Albrecht; Jonathan C Enterline; Jason Cromer; Steven W Levison
Journal:  Neurochem Res       Date:  2006-09-27       Impact factor: 3.996

7.  Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats.

Authors:  Richa B Tripathi; Dana M McTigue
Journal:  J Comp Neurol       Date:  2008-09-10       Impact factor: 3.215

8.  Inhibition of the Jak-STAT pathway prevents CNTF-mediated survival of axotomized oxytocinergic magnocellular neurons in organotypic cultures of the rat supraoptic nucleus.

Authors:  Jason M Askvig; David Y Lo; Adam W Sudbeck; Kathryn E Behm; Laura J Leiphon; John A Watt
Journal:  Exp Neurol       Date:  2012-11-01       Impact factor: 5.330

9.  Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination.

Authors:  D J Messersmith; J C Murtie; T Q Le; E E Frost; R C Armstrong
Journal:  J Neurosci Res       Date:  2000-10-15       Impact factor: 4.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.